{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:05:43Z","timestamp":1780416343456,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["SVIN"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p xml:lang=\"en\">Chronic subdural hematoma has a rising incidence and a high burden of disability and mortality worldwide. The disease process once thought to be from an insidious venous hemorrhage is now believed to be related to chronic inflammation and angiogenesis mediated by vascular endothelial growth factor and other angiogenic factors. Middle meningeal artery embolization is being increasingly used as sole therapy or as a surgical adjunct in the management of chronic subdural hematoma. However, this treatment has risk of migration of embolic material in the presence of unrecognized anastomoses with the retina or other neural tissue. Bevacizumab is a vascular endothelial growth factor\u2010A receptor antagonist used in the treatment of a number of diseases. We herein report the first case of intraarterial bevacizumab injection in the middle meningeal artery for the treatment of chronic subdural hematoma.<\/jats:p>","DOI":"10.1161\/svin.122.000722","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T12:08:30Z","timestamp":1677326910000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Intraarterial Bevacizumab Administration Through the Middle Meningeal Artery for Chronic Subdural Hematoma"],"prefix":"10.1161","volume":"3","author":[{"given":"Jane","family":"Khalife","sequence":"first","affiliation":[{"name":"Department of Neurology Cooper University Health Care Cooper School of Medicine at Rowan University Camden NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-1820","authenticated-orcid":false,"given":"Daniel A.","family":"Tonetti","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery Cooper University Health Care Cooper School of Medicine at Rowan University Camden NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery Cooper University Health Care Cooper School of Medicine at Rowan University Camden NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Jovin","sequence":"additional","affiliation":[{"name":"Department of Neurology Cooper University Health Care Cooper School of Medicine at Rowan University Camden NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratit","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Neurology Cooper University Health Care Cooper School of Medicine at Rowan University Camden NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-3152","authenticated-orcid":false,"given":"Ajith","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery Cooper University Health Care Cooper School of Medicine at Rowan University Camden NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10143-011-0349-y","article-title":"The surgical management of chronic subdural hematoma","volume":"35","author":"Ducruet AF","year":"2012","unstructured":"Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Anderson K, Sussman E, Carpenter A, Connolly ES. The surgical management of chronic subdural hematoma. Neurosurg Rev. 2012;35:155\u2010169. https:\/\/doi.org\/10.1007\/s10143\u2010011\u20100349\u2010y","journal-title":"Neurosurg Rev"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.wneu.2012.06.026","article-title":"Chronic subdural hematoma: a sentinel health event","volume":"80","author":"Dumont TM","year":"2013","unstructured":"Dumont TM, Rughani AI, Goeckes T, Tranmer BI. Chronic subdural hematoma: a sentinel health event. World Neurosurg. 2013;80:889\u2010892. https:\/\/doi.org\/10.1016\/j.wneu.2012.06.026","journal-title":"World Neurosurg"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106458","article-title":"Significantly high concentrations of vascular endothelial growth factor in chronic subdural hematoma with trabecular formation","volume":"202","author":"Takei J","year":"2021","unstructured":"Takei J, Tanaka T, Yamamoto Y, Hatano K, Ichinose D, Maruyama F, Tochigi S, Hasegawa Y, Murayama Y. Significantly high concentrations of vascular endothelial growth factor in chronic subdural hematoma with trabecular formation. Clin Neurol Neurosurg. 2021;202:106458. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106458","journal-title":"Clin Neurol Neurosurg"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.655316","article-title":"Angiogenesis inhibitors in small cell lung cancer","volume":"11","author":"Montanino A","year":"2021","unstructured":"Montanino A, Manzo A, Carillio G, Palumbo G, Esposito G, Sforza V, Costanzo R, Sandomenico C, Botti G, Piccirillo MC, et\u00a0al. Angiogenesis inhibitors in small cell lung cancer. Front Oncol. 2021;11:655316. https:\/\/doi.org\/10.3389\/fonc.2021.655316","journal-title":"Front Oncol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61115-6"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/02688690410001660418","article-title":"Concepts of neurosurgical management of chronic subdural haematoma: historical perspectives","volume":"18","author":"Weigel R","year":"2004","unstructured":"Weigel R, Krauss J, Schmiedek P. Concepts of neurosurgical management of chronic subdural haematoma: historical perspectives. Br J Neurosurg. 2004;18:8\u201018. https:\/\/doi.org\/10.1080\/02688690410001660418","journal-title":"Br J Neurosurg."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3171\/2010.8.JNS10298","article-title":"Chronic subdural hematoma in the elderly: not a benign disease: clinical article","volume":"114","author":"Miranda LB","year":"2011","unstructured":"Miranda LB, Braxton E, Hobbs J, Quigley MR. Chronic subdural hematoma in the elderly: not a benign disease: clinical article. J Neurosurg. 2011;114:72\u201076. https:\/\/doi.org\/10.3171\/2010.8.JNS10298.","journal-title":"J Neurosurg."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000255"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12974-017-0881-y","article-title":"Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy","volume":"14","author":"Edlmann E","year":"2017","unstructured":"Edlmann E, Giorgi\u2010Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 2017;14:108. https:\/\/doi.org\/10.1186\/s12974\u2010017\u20100881\u2010y","journal-title":"J Neuroinflammation"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/2012.10.JNS12327","article-title":"PlGF and SVEGFR\u20101 in chronic subdural hematoma: implications for hematoma development: clinical article","volume":"118","author":"Kalamatianos T","year":"2013","unstructured":"Kalamatianos T, Stavrinou LC, Koutsarnakis C, Psachoulia C, Sakas DE, Stranjalis G. PlGF and SVEGFR\u20101 in chronic subdural hematoma: implications for hematoma development: clinical article. J Neurosurg. 2013;118:353\u2010357. https:\/\/doi.org\/10.3171\/2012.10.JNS12327","journal-title":"J Neurosurg"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2005.22.518"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.surneu.2008.01.023","article-title":"Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma","volume":"71","author":"Hong H\u2010J","year":"2009","unstructured":"Hong H\u2010J, Kim Y\u2010J, Yi H\u2010J, Ko Y, Oh S\u2010J, Kim J\u2010M. Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol. 2009;71:161\u2010165. https:\/\/doi.org\/10.1016\/j.surneu.2008.01.023","journal-title":"Surg Neurol"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3174\/ajnr.A1987","article-title":"Bevacizumab (Avastin)","volume":"31","author":"Mukherji SK","year":"2010","unstructured":"Mukherji SK. Bevacizumab (Avastin). Am J Neuroradiol. 2010;31:235. https:\/\/doi.org\/10.3174\/ajnr.A1987","journal-title":"Am J Neuroradiol"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/neurintsurg-2019-014730","article-title":"Middle meningeal artery embolization for the management of chronic subdural hematoma","volume":"11","author":"Fiorella D","year":"2019","unstructured":"Fiorella D, Arthur AS. Middle meningeal artery embolization for the management of chronic subdural hematoma. J Neurointerv Surg. 2019;11:912. https:\/\/doi.org\/10.1136\/neurintsurg\u20102019\u2010014730","journal-title":"J Neurointerv Surg"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/neurintsurg-2021-017352","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta\u2010analysis","volume":"13","author":"Ironside N","year":"2021","unstructured":"Ironside N, Nguyen C, Do Q, Ugiliweneza B, Chen, C\u2010J, Sieg EP, James RF, Ding D. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta\u2010analysis. J Neurointerv Surg. 2021;13:951. https:\/\/doi.org\/10.1136\/neurintsurg\u20102021\u2010017352","journal-title":"J Neurointerv Surg"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.wneu.2018.11.167","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: meta\u2010analysis and systematic review","volume":"122","author":"Srivatsan A","year":"2019","unstructured":"Srivatsan A, Mohanty A, Nascimento FA, Hafeez MU, Srinivasan VM, Thomas A, Chen SR, Johnson JN, Kan P. Middle meningeal artery embolization for chronic subdural hematoma: meta\u2010analysis and systematic review. World Neurosurg. 2019;122:613\u2010619. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.167","journal-title":"World Neurosurg"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3174\/ajnr.A6739","article-title":"Middle meningeal artery: anatomy and variations","volume":"41","author":"Bonasia S","year":"2020","unstructured":"Bonasia S, Smajda S, Ciccio G, Robert T. Middle meningeal artery: anatomy and variations. Am J Neuroradiol. 2020;41:1777. https:\/\/doi.org\/10.3174\/ajnr.A6739.","journal-title":"Am J Neuroradiol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/neurintsurg-2020-016798","article-title":"Neuroanatomy of cranial dural vessels: implications for subdural hematoma embolization","volume":"13","author":"Shapiro M","year":"2021","unstructured":"Shapiro M, Walker M, Carroll KT, Levitt MR, Raz E, Nossek E, Delavari N, Mir O, Nelson PK. Neuroanatomy of cranial dural vessels: implications for subdural hematoma embolization. J Neurointerv Surg. 2021;13:471. https:\/\/doi.org\/10.1136\/neurintsurg\u20102020\u2010016798","journal-title":"J Neurointerv Surg"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11060-015-2025-5","article-title":"The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?","volume":"127","author":"Blumenthal DT","year":"2016","unstructured":"Blumenthal DT, Mendel L, Bokstein F. The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter? J Neurooncol. 2016;127:493\u2010502. https:\/\/doi.org\/10.1007\/s11060\u2010015\u20102025\u20105","journal-title":"J Neurooncol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3171\/2010.9.JNS101223","article-title":"Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood\u2010brain barrier disruption for recurrent malignant glioma: clinical article","volume":"114","author":"Boockvar JA","year":"2011","unstructured":"Boockvar JA Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K, Seedial SM, Pannullo SC, Schwartz TH, Stieg P, et\u00a0al. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood\u2010brain barrier disruption for recurrent malignant glioma: clinical article. J Neurosurg. 2011;114:624\u2010632. https:\/\/doi.org\/10.3171\/2010.9.JNS101223","journal-title":"J Neurosurg"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/neurintsurg-2021-018327","article-title":"Total 1\u2010year hospital cost of middle meningeal artery embolization compared to surgery for chronic subdural hematomas: a propensity\u2010adjusted analysis","volume":"14","author":"Catapano JS","year":"2022","unstructured":"Catapano JS, Koester SW, Srinivasan VM, Rumalla K, Baranoski JF, Rutledge C, Cole TS, Winkler EA, Lawton MT, Jadhav AP, et\u00a0al. Total 1\u2010year hospital cost of middle meningeal artery embolization compared to surgery for chronic subdural hematomas: a propensity\u2010adjusted analysis. J Neurointerv Surg. 2022;14:804. https:\/\/doi.org\/10.1136\/neurintsurg\u20102021\u2010018327","journal-title":"J Neurointerv Surg"},{"key":"e_1_3_2_23_2","first-page":"01746","article-title":"Cost comparison for open surgery versus middle meningeal artery embolization in patients with chronic subdural hematomas: a propensity score matched analysis","author":"Salih M","year":"2022","unstructured":"Salih M, Khorasanizadeh M, McMillan N, Gomez\u2010Paz S, Thomas AJ, Ogilvy CS, Moore J. Cost comparison for open surgery versus middle meningeal artery embolization in patients with chronic subdural hematomas: a propensity score matched analysis. World Neurosurg. 2022;S1878\u20108750:01746\u20106. https:\/\/doi.org\/10.1016\/j.wneu.2022.12.042","journal-title":"World Neurosurg"},{"issue":"3","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10143-016-0704-0","article-title":"A case of complete clearance of chronic subdural hematoma accompanied by recurrent glioblastoma multiforme after administration of bevacizumab","volume":"39","author":"Suzuki K","year":"2016","unstructured":"Suzuki K, Kawataki T, Kanemaru K, Mitsuka K, Ogiwara M, Sato H, Kinouchi H. A case of complete clearance of chronic subdural hematoma accompanied by recurrent glioblastoma multiforme after administration of bevacizumab. Neurosurg Rev. 2016;39(3):525\u2010529. https:\/\/doi.org\/10.1007\/s10143-016-0704-0","journal-title":"Neurosurg Rev"}],"container-title":["Stroke: Vascular and Interventional Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/SVIN.122.000722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:43:50Z","timestamp":1715615030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/SVIN.122.000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1161\/SVIN.122.000722"],"URL":"https:\/\/doi.org\/10.1161\/svin.122.000722","relation":{},"ISSN":["2694-5746"],"issn-type":[{"value":"2694-5746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2022-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e000722"}}